-
Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans
22 Apr 2025 12:10 GMT
… , non-drug, prescribed migraine treatment, the Nerivio® REN … most chronic diseases, migraine treatment remains overwhelmingly reactive, relying … (dual-use) prescription migraine treatment that works without drugs, … a non-drug migraine treatment that can be …
-
Patient Advocate and Migraine Expert Discuss Drug-Free Migraine Treatment Options with YourUpdateTV
21 Apr 2025 18:42 GMT
… growing role of drug-free migraine treatment and the importance of patient … more information about drug-free migraine treatment options and tools for insurance … for broader insurance coverage of migraine treatments, encouraging others to push for …
-
AbbVie Stock: Q1 Earnings Beat and EPS Outlook Raised
27 Apr 2025 15:45 GMT
… Vraylar (up 10.3%), and migraine treatments Ubrelvy and Qulipta.
Oncology sales …
-
Promising developments in migraine treatment
20 Apr 2025 15:07 GMT
There are two developments in migraine treatment that will help bring relief …
-
Drug Free Migraine Treatment on Coast Live
18 Apr 2025 23:46 GMT
Posted
HAMPTON ROADS—VA-- Migraine disease affects millions of Americans, but the treatments can cause many side effects that make it hard for sufferers to function. Now, there is an FDA-approved, drug-free, and needle-free treatment called The Nerivio REN …
-
Innovative drug-free migraine treatment now accessible to millions of Americans
18 Apr 2025 23:32 GMT
This segment is sponsored by Nerivio.
Millions of Americans suffer from migraine, but now, an innovative and drug-free treatment option is making it easier for people to access the care they need.
Today we were joined by Dr. Aliya Fredrick and Sarah …
-
Migraine Treatment Zavegepant Shows No Meaningful Impact on Oral Contraceptive Exposure
17 Apr 2025 11:06 GMT
… by the FDA for acute migraine treatment, did not meaningfully alter the …
-
Wearable migraine treatment for adults and children as young as 8-years-old
16 Apr 2025 18:40 GMT
-
Click Therapeutics granted FDA market authorization for digital migraine drug
15 Apr 2025 23:23 GMT
… taking standard-of-care prescription migraine medications.
Data from the ReMMiD-C …
-
Click Therapeutics gets FDA authorization for migraine treatment
15 Apr 2025 21:49 GMT
In a sign of life for the digital therapeutics industry, Click Therapeutics has received FDA authorization for its treatment.
The FDA has given marketing authorization …
Sign up to read this article for free.
Get free access to a …